BIOSTEM TECHNOLOGIES (BSEM)

OTC Biotechnology Diagnostics SIC: 2836
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (2)

NCT #TitlePhaseStatusEnrollment
NCT06811909 Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC OTHER Recruiting 60
NCT06565156 Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM OTHER Active Not Recruiting 72

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis